65° F
May
23
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Qsymia

Highlights

A collection of news and information related to Qsymia published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-5 of 5
» View baltimoresun.com items only
    May 23, 2013 |Story| Reuters

  1. Denner added as nominee to Vivus board by activist investor

    Reuters
    By Bill Berkrot May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner and two others to its slate of...

    Tags: Companies and Corporations, ImClone Systems Incorporated, Vivus Inc., Drugs and Medicines, Lilly Eli & Co

    2. Dec 5, 2012 |Story| Chicago Tribune

  2. Weigh pros and cons of 2 new diet drugs

    Weight-loss drugs have so far been a complete bust. But they may be verging on a comeback, now that the Food and Drug Administration has approved two new prescription diet pills for the first time in more than a decade.
    Weight-loss drugs have so far been a complete bust. But they may be verging on a comeback, now that the Food and Drug Administration has approved two new prescription diet pills for the first time in more than a decade. Both weight-loss medications...

    Tags: Migraine, High Cholesterol, Body Mass Index, Chemical Industry, George Washington University

    3. Jul 17, 2012 |Story| CNN

  3. FDA approves new diet drug

    The Food and Drug Administration approved a new prescription diet drug called Qsymia on Tuesday. The medication produced dramatic weight loss in clinical trials, but some are concerned over potential side effects, including increased heart rate, birth defects and other issues.
    CNN
    The Food and Drug Administration approved a new prescription diet drug called Qsymia on Tuesday. The medication produced dramatic weight loss in clinical trials, but some are concerned over potential side effects, including increased heart rate, birth...

    Tags: Migraine, Weight Loss, Body Mass Index, Chemical Industry, Trials

    4. Jun 27, 2012 |Story| Los Angeles Times

  4. FDA approves lorcaserin, first weight-loss drug since 1999

    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...

    Tags: Weight Loss, Arena Pharmaceuticals, Inc., High Cholesterol, Body Mass Index, Chemical Industry

    5. Mar 29, 2012 |Story| Reuters

  5. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Weight Loss, Arena Pharmaceuticals, Inc., Abbott Laboratories, Trials, Vivus Inc.

Original site for Qsymia topic gallery.